Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Sales: 2010-2025

Historic Return on Sales for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to 0.03%.

  • OptimizeRx's Return on Sales rose 4600.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 0.17% for FY2024, which is 800.0% up from last year.
  • As of Q3 2025, OptimizeRx's Return on Sales stood at 0.03%, which was up 4600.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Return on Sales ranged from a high of 0.15% in Q4 2024 and a low of 0.49% during Q1 2023
  • Over the past 5 years, OptimizeRx's median Return on Sales value was 0.18% (recorded in 2023), while the average stood at 0.16%.
  • In the last 5 years, OptimizeRx's Return on Sales crashed by -4000bps in 2023 and then surged by 5600bps in 2024.
  • Quarter analysis of 5 years shows OptimizeRx's Return on Sales stood at 0.03% in 2021, then tumbled by -154bps to 0.02% in 2022, then tumbled by -2396bps to 0.41% in 2023, then surged by 135bps to 0.15% in 2024, then plummeted by -80bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.05% for Q2 2025, and 0.1% during Q1 2025.